These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 23913859)
1. Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases. Andrianifahanana M; Wilkes MC; Gupta SK; Rahimi RA; Repellin CE; Edens M; Wittenberger J; Yin X; Maidl E; Becker J; Leof EB FASEB J; 2013 Nov; 27(11):4444-54. PubMed ID: 23913859 [TBL] [Abstract][Full Text] [Related]
2. [Effect of imatinib mesylate on bleomycin-induced pulmonary fibrosis in mice]. Li L; Li YQ Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):229-32. PubMed ID: 17448279 [TBL] [Abstract][Full Text] [Related]
3. Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy. Thomson S; Petti F; Sujka-Kwok I; Epstein D; Haley JD Clin Exp Metastasis; 2008; 25(8):843-54. PubMed ID: 18696232 [TBL] [Abstract][Full Text] [Related]
4. Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice. Rhee CK; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim YK; Kim KH; Kim TJ; Kim JW Respiration; 2011; 82(3):273-87. PubMed ID: 21659722 [TBL] [Abstract][Full Text] [Related]
5. Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor. Abouantoun TJ; MacDonald TJ Mol Cancer Ther; 2009 May; 8(5):1137-47. PubMed ID: 19417143 [TBL] [Abstract][Full Text] [Related]
6. Role of platelet-derived growth factor/platelet-derived growth factor receptor axis in the trafficking of circulating fibrocytes in pulmonary fibrosis. Aono Y; Kishi M; Yokota Y; Azuma M; Kinoshita K; Takezaki A; Sato S; Kawano H; Kishi J; Goto H; Uehara H; Izumi K; Nishioka Y Am J Respir Cell Mol Biol; 2014 Dec; 51(6):793-801. PubMed ID: 24885373 [TBL] [Abstract][Full Text] [Related]
12. Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats. Yoshiji H; Kuriyama S; Noguchi R; Ikenaka Y; Yoshii J; Yanase K; Namisaki T; Kitade M; Yamazaki M; Asada K; Akahane T; Tsujimoto T; Uemura M; Fukui H Int J Mol Med; 2006 May; 17(5):899-904. PubMed ID: 16596278 [TBL] [Abstract][Full Text] [Related]
13. Towards predicting the lung fibrogenic activity of MWCNT: Key role of endocytosis, kinase receptors and ERK 1/2 signaling. Vietti G; Ibouraadaten S; Palmai-Pallag M; Yakoub Y; Piret JP; Marbaix E; Lison D; van den Brule S Nanotoxicology; 2016; 10(4):488-500. PubMed ID: 26444902 [TBL] [Abstract][Full Text] [Related]
14. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235 [TBL] [Abstract][Full Text] [Related]
15. Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells. Kinoshita K; Nakagawa K; Hamada J; Hida Y; Tada M; Kondo S; Moriuchi T Int J Oncol; 2010 Oct; 37(4):869-77. PubMed ID: 20811709 [TBL] [Abstract][Full Text] [Related]
16. Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis. Akhmetshina A; Venalis P; Dees C; Busch N; Zwerina J; Schett G; Distler O; Distler JH Arthritis Rheum; 2009 Jan; 60(1):219-24. PubMed ID: 19116940 [TBL] [Abstract][Full Text] [Related]
17. Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases. Vittal R; Zhang H; Han MK; Moore BB; Horowitz JC; Thannickal VJ J Pharmacol Exp Ther; 2007 Apr; 321(1):35-44. PubMed ID: 17218487 [TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Perros F; Montani D; Dorfmüller P; Durand-Gasselin I; Tcherakian C; Le Pavec J; Mazmanian M; Fadel E; Mussot S; Mercier O; Hervé P; Emilie D; Eddahibi S; Simonneau G; Souza R; Humbert M Am J Respir Crit Care Med; 2008 Jul; 178(1):81-8. PubMed ID: 18420966 [TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282 [TBL] [Abstract][Full Text] [Related]
20. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. Aono Y; Nishioka Y; Inayama M; Ugai M; Kishi J; Uehara H; Izumi K; Sone S Am J Respir Crit Care Med; 2005 Jun; 171(11):1279-85. PubMed ID: 15735062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]